Patients injected biphasic insulin twice daily, prandial insulin immediately before meals, and basal insulin at bedtime. Visits with patients were scheduled at 2, 6, 12, 24, 38, and 52 weeks, with ...

Sidebar Key Issues. IMPROVE™ is the largest observational study of patients with Type 2 diabetes mellitus to date. Baseline glycemic control (prior to starting biphasic insulin aspart 30/70 ...

Twice-Daily Use of Biphasic Insulin Aspart 30 (BIAsp 30): Comparative Studies A total of seven publications (three papers and four abstracts) from five studies were identified that compared twice ...

Patients were randomly assigned to receive twice-daily biphasic insulin aspart (NovoMix 30), three-times-daily prandial insulin aspart (NovoRapid), or once-daily (twice if required) basal insulin ...

Holman and colleagues randomly assigned 235 patients to receive twice-daily biphasic insulin aspart (NovoMix 30, Novo Nordisk), 239 patients to three times-daily prandial insulin aspart (NovoRapid ...

Biphasic insulin preparations are useful in patients with type 1 diabetes who cannot or will not pursue intensive management goals or who have visual, motor, or cognitive impairments, ...

Premixed or biphasic insulin regimen: 74.7% vs 74.5% Basal-bolus insulin regimen: 81.1% vs 73.3% Physicians were generally pleased with the iNCDSS, giving it an overall satisfaction score of 4.1 ...

A major international diabetes study of more than 52,000 patients from eight countries has shown that using biphasic BIAsp 30 insulin resulted in significant clinical improvements and greater ...

PARIS, June 28, 2021 /PRNewswire/ -- A new study of Soliqua® 100/33 (insulin glargine and lixisenatide injection) 100 Units/mL and 33 mcg/mL, iGla ...

Drug company Novo Nordisk's decision to pull its Mixtard 30 insulin drug from the UK could add £9 million to the NHS drugs bill in England alone, says an editorial in the Drug and Therapeutics ...

Premixed or biphasic insulin regimen: 74.7% vs 74.5% Basal-bolus insulin regimen: 81.1% vs 73.3% Physicians were generally pleased with the iNCDSS, giving it an overall satisfaction score of 4.1 ...